Search Within

Michael Morris

Formats
  1. Meeting Abstract (275)
  2. Journal Article (268)
  3. Review (19)
  4. Book Section (6)
  5. Editorial (6)
  6. Correspondence (4)
  7. Guidelines (3)
  8. Miscellaneous (2)
  9. Conference Paper (1)
Groups
  1. Department of Medicine (584)
  2. Genitourinary Oncology Service (584)
  3. Solid Tumor Oncology Division (584)
  4. Radiology, Department of (164)
  5. GSK Faculty (161)
  6. Molecular Imaging and Therapy Service (141)

More Groups

People
  1. Howard Scher (217)
  2. Steven Larson (93)
  3. Susan Slovin (90)
  4. Dana Rathkopf (79)
  5. Daniel Danila (54)
  6. Glenn Heller (54)

More People

Years
  1. 2025 (25)
  2. 2024 (50)
  3. 2023 (40)
  4. 2022 (50)
  5. 2021 (42)
  6. 2020 (35)

More Years

Publications
  1. Journal of Clinical Oncology (240)
  2. Journal of Nuclear Medicine (44)
  3. Clinical Cancer Research (33)
  4. Annals of Oncology (30)
  5. Cancer (18)
  6. European Urology (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (250)
  2. Society of Nuclear Medicine (44)
  3. American Association for Cancer Research (43)
  4. Oxford University Press (41)
  5. Elsevier Science, Inc. (40)
  6. Elsevier Inc. (27)

More Publishers

Results (584)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase Ill trial of docetaxel versus docetaxel and radium-223 (Ra-223) in patients with metastatic castration-resistant prostate cancer (mCRPC): DORA
    Meeting Abstract

    Morris, M. J.; De Wit, R.; Vogelzang, N. J.; Tagawa, S. T.; Higano, C. S.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinicopathologic and genomic characterization of parenchymal brain metastases (BM) in prostate cancer (PCa)
    Meeting Abstract

    Mota, J. M. S. C.; Teo, M. Y.; Knezevic, A.; Bambury, R. M.; Hatzoglou, V.; Autio, K. A.; Abida, W.; Gopalan, A.; Fine, S.; Danila, D. C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Tumor testing in men with prostate cancer to predict for germline DNA-damage repair mutations
    Meeting Abstract

    Carlo, M. I.; Kemel, Y.; Breen, K.; Cadoo, K. A.; Walsh, M. F.; Abida, W.; Autio, K. A.; Danila, D. C.; Kampel, L. J.; Morris, M. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Alliance A031501: Phase III randomized adjuvant study of MK-3475 (pembrolizumab) in muscle-invasive and locally advanced urothelial carcinoma (MIBC) (AMBASSADOR) versus observation
    Meeting Abstract

    Apolo, A. B.; Rosenberg, J. E.; Kim, W. Y.; Chen, R. C.; Sonpavde, G.; Srinivas, S.; Mortazavi, A.; Watt, C.; Mallek, M.; Graap, K.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer
    Journal Article

    McHugh, D.; Eisenberger, M.; Heath, E. I.; Bruce, J.; Danila, D. C.; Rathkopf, D. E.; Feldman, J.; Slovin, S. F.; Anand, B.; Chu, R.; more...
    Investigational New Drugs (2019)

    Fulltext@MSK | Save
  • PD-L1 expression and clinical outcomes to cabozantinib, everolimus, and sunitinib in patients with metastatic renal cell carcinoma: Analysis of the randomized clinical trials METEOR and CABOSUN
    Journal Article

    Flaifel, A.; Xie, W.; Braun, D. A.; Ficial, M.; Bakouny, Z.; Nassar, A. H.; Jennings, R. B.; Escudier, B.; George, D. J.; Motzer, R. J.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Assessment of simplified methods for quantification of (18)F-FDHT uptake in patients with metastatic castration-resistant prostate cancer
    Journal Article

    Kramer, G. M.; Yaqub, M.; Vargas, H. A.; Schuit, R. C.; Windhorst, A. D.; van den Eertwegh, A. J. M.; van der Veldt, A. A. M.; Bergman, A. M.; Burnazi, E. M.; Lewis, J. S.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Imaging diagnosis and follow-up of advanced prostate cancer: Clinical perspectives and state of the art
    Review

    Perez-Lopez, R.; Tunariu, N.; Padhani, A. R.; Oyen, W. J. G.; Fanti, S.; Vargas, H. A.; Omlin, A.; Morris, M. J.; de Bono, J.; Koh, D. M.
    Radiology (2019)

    Fulltext@MSK | Save
  • Healthy tissue uptake of (68)Ga-prostate-specific membrane antigen, (18)F-DCFPyL, (18)F-fluoromethylcholine, and (18)F-dihydrotestosterone
    Journal Article

    Jansen, B. H. E.; Kramer, G. M.; Cysouw, M. C. F.; Yaqub, M. M.; de Keizer, B.; Lavalaye, J.; Booij, J.; Vargas, H. A.; Morris, M. J.; Vis, A. N.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Sensitivity of (18)F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer
    Journal Article

    Cysouw, M. C. F.; Kramer, G. M.; Heijtel, D.; Schuit, R. C.; Morris, M. J.; van den Eertwegh, A. J. M.; Voortman, J.; Hoekstra, O. S.; Oprea-Lager, D. E.; Boellaard, R.
    EJNMMI Research (2019)

    Fulltext@MSK | Save